Pricing
Login
Home
Charts
Search
Watchlist
Products

Ind-Swift Laboratories Ltd

INDSWFTLAB
NSE
₹349.05+3.59%9 Nov 2026
Reports
Pharma Formulations

Ind-Swift Laboratories Ltd

INDSWFTLAB
NSE
₹349.05
+3.59%
9 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹3,035Cr
Close
Close Price
₹349.05
Industry
Industry
Pharma Formulations
PE
Price To Earnings
35.76
PS
Price To Sales
4.03
Revenue
Revenue
₹753Cr
Rev Gr TTM
Revenue Growth TTM
30.11%
PAT Gr TTM
PAT Growth TTM
-64.30%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
2885293312129138153159151170191240
Growth YoY
Revenue Growth YoY%
-8.173.7-89.3-95.9-55.2-73.8360.41,226.417.122.825.451.6
Expenses
ExpensesCr
2364374324135147149151147149158195
Operating Profit
Operating ProfitCr
5291-10-12-7-9474213345
OPM
OPM%
18.017.3-29.4-98.6-5.2-6.72.44.72.812.117.518.9
Other Income
Other IncomeCr
7458111316220151222-377
Interest Expense
Interest ExpenseCr
2130010-27121-211
Depreciation
DepreciationCr
14200067779888
PBT
PBTCr
2452711-7230101016123343
Tax
TaxCr
53300-18227-389
PAT
PATCr
2049410-62229810152534
Growth YoY
PAT Growth YoY%
-29.32,071.2-94.2-98.7-128.2-55.0756.41,910.0273.1-93.2184.1324.8
NPM
NPM%
6.893.43.03.3-4.3160.85.75.16.38.912.814.2
EPS
EPS₹
3.383.50.20.1-0.833.01.31.01.21.82.83.9
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
2885293312129138153159151170191240
Growth YoY
Revenue Growth YoY%
-8.173.7-89.3-95.9-55.2-73.8360.41,226.417.122.825.451.6
Expenses
ExpensesCr
2364374324135147149151147149158195
Operating Profit
Operating ProfitCr
5291-10-12-7-9474213345
OPM
OPM%
18.017.3-29.4-98.6-5.2-6.72.44.72.812.117.518.9
Other Income
Other IncomeCr
7458111316220151222-377
Interest Expense
Interest ExpenseCr
2130010-27121-211
Depreciation
DepreciationCr
14200067779888
PBT
PBTCr
2452711-7230101016123343
Tax
TaxCr
53300-18227-389
PAT
PATCr
2049410-62229810152534
Growth YoY
PAT Growth YoY%
-29.32,071.2-94.2-98.7-128.2-55.0756.41,910.0273.1-93.2184.1324.8
NPM
NPM%
6.893.43.03.3-4.3160.85.75.16.38.912.814.2
EPS
EPS₹
3.383.50.20.1-0.833.01.31.01.21.82.83.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6537167657577808911,0391,2071,281574649753
Growth
Revenue Growth%
-1.19.66.9-1.23.014.316.516.26.1-55.213.030.1
Expenses
ExpensesCr
5446106316316357098439781,027581602649
Operating Profit
Operating ProfitCr
109106134126144183196229254-747104
OPM
OPM%
16.714.817.616.718.520.518.819.019.9-1.27.213.8
Other Income
Other IncomeCr
-1151612033234474322923633
Interest Expense
Interest ExpenseCr
106882892107100969251310
Depreciation
DepreciationCr
85888710490871315753243132
PBT
PBTCr
-83-553650-2018138758225851104
Tax
TaxCr
-24-16142112115391607821
PAT
PATCr
-59-392229-21-3-2484212514383
Growth
PAT Growth%
50.833.3156.231.7-173.285.231.72,325.6781.1-40.6-82.8-64.3
NPM
NPM%
-9.0-5.52.93.8-2.7-0.3-0.24.032.943.66.611.1
EPS
EPS₹
-14.3-9.24.9-6.2-4.3-0.5-0.48.191.237.35.29.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6537167657577808911,0391,2071,281574649753
Growth
Revenue Growth%
-1.19.66.9-1.23.014.316.516.26.1-55.213.030.1
Expenses
ExpensesCr
5446106316316357098439781,027581602649
Operating Profit
Operating ProfitCr
109106134126144183196229254-747104
OPM
OPM%
16.714.817.616.718.520.518.819.019.9-1.27.213.8
Other Income
Other IncomeCr
-1151612033234474322923633
Interest Expense
Interest ExpenseCr
106882892107100969251310
Depreciation
DepreciationCr
85888710490871315753243132
PBT
PBTCr
-83-553650-2018138758225851104
Tax
TaxCr
-24-16142112115391607821
PAT
PATCr
-59-392229-21-3-2484212514383
Growth
PAT Growth%
50.833.3156.231.7-173.285.231.72,325.6781.1-40.6-82.8-64.3
NPM
NPM%
-9.0-5.52.93.8-2.7-0.3-0.24.032.943.66.611.1
EPS
EPS₹
-14.3-9.24.9-6.2-4.3-0.5-0.48.191.237.35.29.8

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
424546486060606059698787
Reserves
ReservesCr
4764865075405815445416228721,0301,2971,387
Current Liabilities
Current LiabilitiesCr
9511,005936356323315334371221221257262
Non Current Liabilities
Non Current LiabilitiesCr
74660153498090690186577112453235
Total Liabilities
Total LiabilitiesCr
2,2152,1382,0231,9241,8701,8181,8011,8241,1651,4381,6731,771
Current Assets
Current AssetsCr
9268328428368639441,0751,1656618659771,023
Non Current Assets
Non Current AssetsCr
1,2881,3061,1811,0881,007874725660504573697748
Total Assets
Total AssetsCr
2,2152,1382,0231,9241,8701,8181,8011,8241,1651,4381,6731,771
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
424546486060606059698787
Reserves
ReservesCr
4764865075405815445416228721,0301,2971,387
Current Liabilities
Current LiabilitiesCr
9511,005936356323315334371221221257262
Non Current Liabilities
Non Current LiabilitiesCr
74660153498090690186577112453235
Total Liabilities
Total LiabilitiesCr
2,2152,1382,0231,9241,8701,8181,8011,8241,1651,4381,6731,771
Current Assets
Current AssetsCr
9268328428368639441,0751,1656618659771,023
Non Current Assets
Non Current AssetsCr
1,2881,3061,1811,0881,007874725660504573697748
Total Assets
Total AssetsCr
2,2152,1382,0231,9241,8701,8181,8011,8241,1651,4381,6731,771

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
799673-64125135150195-163-29-68
Investing Cash Flow
Investing Cash FlowCr
-30-31-17-12-9-105-13-104-113-73
Financing Cash Flow
Financing Cash FlowCr
-48-69-62100-133-124-141-18669972142
Net Cash Flow
Net Cash FlowCr
2-4-623-17114-4431-691
Free Cash Flow
Free Cash FlowCr
497553-79115131137182-205-55-155
CFO To PAT
CFO To PAT%
-135.3-244.2332.6-222.5-591.1-4,287.9-6,992.4406.9-38.7-11.4-158.4
CFO To EBITDA
CFO To EBITDA%
72.990.254.4-51.186.773.876.884.9-64.2418.1-145.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
799673-64125135150195-163-29-68
Investing Cash Flow
Investing Cash FlowCr
-30-31-17-12-9-105-13-104-113-73
Financing Cash Flow
Financing Cash FlowCr
-48-69-62100-133-124-141-18669972142
Net Cash Flow
Net Cash FlowCr
2-4-623-17114-4431-691
Free Cash Flow
Free Cash FlowCr
497553-79115131137182-205-55-155
CFO To PAT
CFO To PAT%
-135.3-244.2332.6-222.5-591.1-4,287.9-6,992.4406.9-38.7-11.4-158.4
CFO To EBITDA
CFO To EBITDA%
72.990.254.4-51.186.773.876.884.9-64.2418.1-145.6

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1871482591871284263923265815091,1413,035
Price To Earnings
Price To Earnings
12.06.56.91.42.326.535.8
Price To Sales
Price To Sales
0.30.20.30.30.20.50.40.30.50.91.84.0
Price To Book
Price To Book
0.80.60.90.50.31.11.00.70.60.50.82.1
EV To EBITDA
EV To EBITDA
13.010.78.110.37.87.66.85.10.7-17.015.625.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
38.334.239.937.941.141.739.036.040.241.146.646.6
OPM
OPM%
16.714.817.616.718.520.518.819.019.9-1.27.213.8
NPM
NPM%
-9.0-5.52.93.8-2.7-0.3-0.24.032.943.66.611.1
ROCE
ROCE%
1.32.24.68.25.37.57.011.666.823.03.77.0
ROE
ROE%
-11.3-7.44.04.9-3.3-0.5-0.47.045.322.83.15.7
ROA
ROA%
-2.6-1.81.11.5-1.1-0.2-0.12.636.217.42.64.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1871482591871284263923265815091,1413,035
Price To Earnings
Price To Earnings
12.06.56.91.42.326.535.8
Price To Sales
Price To Sales
0.30.20.30.30.20.50.40.30.50.91.84.0
Price To Book
Price To Book
0.80.60.90.50.31.11.00.70.60.50.82.1
EV To EBITDA
EV To EBITDA
13.010.78.110.37.87.66.85.10.7-17.015.625.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
38.334.239.937.941.141.739.036.040.241.146.646.6
OPM
OPM%
16.714.817.616.718.520.518.819.019.9-1.27.213.8
NPM
NPM%
-9.0-5.52.93.8-2.7-0.3-0.24.032.943.66.611.1
ROCE
ROCE%
1.32.24.68.25.37.57.011.666.823.03.77.0
ROE
ROE%
-11.3-7.44.04.9-3.3-0.5-0.47.045.322.83.15.7
ROA
ROA%
-2.6-1.81.11.5-1.1-0.2-0.12.636.217.42.64.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Pharma Formulations
Market CapitalizationMkt CapCr4,7574,2944,0013,0352,6022,2362,093
Close PriceClose₹474.352,596.003,856.40349.051,519.40506.101,881.60
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE64.8038.7349.3835.7646.1884.7738.64
Price To SalesPS4.855.627.224.032.993.354.71
RevenueRevenueCr981764554753870668444
Revenue Growth TTMRev Gr TTM%16.7%14.7%37.9%30.1%15.2%
PAT Growth TTMPAT Gr TTM%18.7%-48.5%86.8%-64.3%27.3%
Market CapitalizationMkt CapCr4,7574,2944,0013,0352,6022,2362,093
Close PriceClose₹474.352,596.003,856.40349.051,519.40506.101,881.60
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE64.8038.7349.3835.7646.1884.7738.64
Price To SalesPS4.855.627.224.032.993.354.71
RevenueRevenueCr981764554753870668444
Revenue Growth TTMRev Gr TTM%16.7%14.7%37.9%30.1%15.2%
PAT Growth TTMPAT Gr TTM%18.7%-48.5%86.8%-64.3%27.3%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Mar 26
Result
PPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
ResultPPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Mar 26
Result
PPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
ResultPPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews